Tuesday, January 12, 2021 11:02:40 AM
Smart!
I hate dead money, but it is going to take awhile for RDHL to recove after doubling down on this financing.
Dilution of the share architecture is rarely good for stock price, but this is what a “shelf” offering is there to do.
It is a mine field to innocent buyers: today’s correction is not the last. “Due to demand” for this offering, they more than double down!
What is the old saying? Paying retail is for .....never mind.
I hate dead money, but it is going to take awhile for RDHL to recove after doubling down on this financing.
Dilution of the share architecture is rarely good for stock price, but this is what a “shelf” offering is there to do.
It is a mine field to innocent buyers: today’s correction is not the last. “Due to demand” for this offering, they more than double down!
What is the old saying? Paying retail is for .....never mind.
Recent RDHL News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/14/2026 11:00:07 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 05:14:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 02:00:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/25/2026 12:01:02 PM
- Joint U.S. Commercialization of RedHill's Talicia® Commences • PR Newswire (US) • 02/25/2026 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/02/2026 12:00:34 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/27/2026 12:00:58 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/22/2026 09:06:45 PM
- Form F-1/A - Registration statement for certain foreign private issuers: [Amend] • Edgar (US Regulatory) • 01/22/2026 09:04:43 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/22/2026 01:56:03 PM
- RedHill Biopharma Shares Jump on Progress Toward Treating GLP-1 Side Effects • IH Market News • 01/05/2026 02:59:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2026 12:02:00 PM
- RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects • PR Newswire (US) • 01/05/2026 12:00:00 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 12/31/2025 10:09:48 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/31/2025 09:58:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/23/2025 12:00:39 PM
